Intra-Cellular Therapies, Inc. / Products

    { "items": [ { "from": "Product", "to": "Net revenue", "flow": 680501000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Grant", "to": "Net revenue", "flow": 351000, "colorFrom": "#525f7a", "colorTo": "#525f7a" }, { "from": "Net revenue", "to": "Cost of goods sold", "flow": 48586659.84305698, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Net revenue", "to": "Gross profit", "flow": 531962640.73694986, "colorFrom": "#1d6a54", "colorTo": "#1d6a54" }, { "from": "Other income", "to": "Gross profit", "flow": 499829.40975773335, "colorFrom": "#1d6a54", "colorTo": "#1d6a54" }, { "from": "Gross profit", "to": "R&D expenses", "flow": 201399692.937564, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Gross profit", "to": "SG&A expenses", "flow": 430304503.5823951, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Net loss", "to": "EBITDA", "flow": 99241726.37325145, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "EBITDA", "to": "D&A", "flow": 433299.2152848857, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "Net loss", "to": "EBITDA", "flow": 99557318.32139201, "colorFrom": "#883935", "colorTo": "#883935" }, { "from": "EBIT", "to": "Tax expenses", "flow": 403445.9228932105, "colorFrom": "#883935", "colorTo": "#883935" } ], "priority": [ "Net loss", "Tax credits", "Other income", "Net income", "EBIT", "EBITDA", "Gross profit", "Net revenue", "Product", "Grant", "Cost of goods sold", "R&D expenses", "SG&A expenses", "D&A", "Tax expenses" ] }
    Product Revenue
    Product €680.50M 117.2%
    Grant €351.00K 0.1%

    Notifications